Intas becomes the first and only company in India to offer IVF and gynecology therapies with needle-free injections
The new single-use commercial facility will be among India’s largest, featuring advanced technologies to produce high-quality biologics and specialty pharmaceuticals
Provides pain relief for more than 30 conditions, including chronic back pain, arthritis, and sports injuries
This Breakthrough Therapy Designation highlights the impressive clinical benefit of Enhertu over the current standard of care
The study focused on patients without actionable genomic alterations whose disease had progressed after prior immunotherapy and platinum-based chemotherapy
The company also reported significant progress toward its internally defined Sustainable Development Goals
Xeureka will receive an upfront payment from UBE and will be eligible for milestone payments tied to future research progress
The initiative is focused on a problem that continues to plague cancer outcomes in India
The announcement came during the inauguration of the college’s Innovation & Incubation Centre and Health Club
Takeda said zasocitinib was generally well tolerated, with a safety profile consistent with earlier studies
Subscribe To Our Newsletter & Stay Updated
